Literature DB >> 827228

Studies of regression of advanced atherosclerosis in experimental animals and man.

R W Wissler, D Vesselinovitch.   

Abstract

In general, the results to date in humans and experimental animals seem to indicate that substantial regression of advanced atherosclerosis is possible. The results also indicate that the advanced atherosclerotic lesions are much more likely to respond favorably if the serum cholesterol concentrations are reduced to the minimum that prevails in animals or people who consume a low-fat low-cholesterol diet. In human subjects and in rhesus monkeys, this value appears to be about 150 mg%. Under these circumstances, much of the lipid disappears from the plaques, and the remaining fibrous tissue and cells appear to condense and undergo remodeling, as they do in fracture or wound healing. Additional effort will be required to ascertain how rapidly and how much of the fiber proteins and calcium can be removed from the advanced plaques and to work out methods that will consistently produce regression of advanced atherosclerotic lesions in human subjects. This goal would appear to be worth working toward. Interruption of progression of atherosclerosis appears to be more easily achieved, and it also would appear to be a worthwhile goal. The diagram that is reproduced as FIGURE 2 presents the multiple methods of intervention in atherosclerosis that are now available to the physician and to the patient. To those of us who look on atherosclerosis as an almost completely preventable disease and one that is largely reversible, the following quotation from the perceptive essay by Lewis Thomas seems to be prophetic and most appropriate. An extremely complex and costly technology for the management of coronary heart disease has evolved, involving specialized ambulances and hospital units, all kinds of electronic gadgetry and whole platoons of new professional personnel to deal with the end results of coronary thrombosis. Almost everything offered today for the treatment of heat disease is at this level of technology, with the transplatned and artificial hearts as ultimate examples. When enough has been learned for us to know what really goes wrong in heart disease, we ought to be in a position to figure out ways to prevent or reverse the process; and when this happens, the current elaborate technology will be set to one side.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 827228     DOI: 10.1111/j.1749-6632.1976.tb43368.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  18 in total

1.  In vivo recording of blood velocity profiles and studies in vitro of profile alterations induced by known stenoses.

Authors:  M Bassini; E Gatti; T Longo; G Martinis; P Pignoli; P L Pizzolati
Journal:  Tex Heart Inst J       Date:  1982-06

Review 2.  Atherosclerosis: Making a U Turn.

Authors:  Ira J Goldberg; Gaurav Sharma; Edward A Fisher
Journal:  Annu Rev Med       Date:  2020-01-27       Impact factor: 13.739

Review 3.  Regression of atherosclerosis: insights from animal and clinical studies.

Authors:  Jonathan E Feig
Journal:  Ann Glob Health       Date:  2013-12-25       Impact factor: 2.462

4.  Hyperglycemia impairs atherosclerosis regression in mice.

Authors:  Nathalie Gaudreault; Nikit Kumar; Victor R Olivas; Delphine Eberlé; Kyle Stephens; Robert L Raffai
Journal:  Am J Pathol       Date:  2013-10-08       Impact factor: 4.307

Review 5.  The role of HDL in plaque stabilization and regression: basic mechanisms and clinical implications.

Authors:  Jonathan E Feig; Jessica L Feig; George D Dangas
Journal:  Coron Artery Dis       Date:  2016-11       Impact factor: 1.439

6.  Exendin-4 ameliorates oxidized-LDL-induced inhibition of macrophage migration in vitro via the NF-κB pathway.

Authors:  Ge-fei Ma; Song Chen; Lei Yin; Xiang-dong Gao; Wen-bing Yao
Journal:  Acta Pharmacol Sin       Date:  2013-12-16       Impact factor: 6.150

7.  Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis.

Authors:  D M Small; M G Bond; D Waugh; M Prack; J K Sawyer
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

Review 8.  Dietary prevention of ischaemic heart disease--a policy for the '80s.

Authors:  B Lewis
Journal:  Br Med J       Date:  1980-07-19

Review 9.  High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies.

Authors:  Jonathan E Feig; Bernd Hewing; Jonathan D Smith; Stanley L Hazen; Edward A Fisher
Journal:  Circ Res       Date:  2014-01-03       Impact factor: 17.367

10.  Aging and atherosclerosis in human and nonhuman primates.

Authors:  W T Cefalu; J D Wagner
Journal:  Age (Omaha)       Date:  1997-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.